---
figid: PMC9555085__12935_2022_2738_Fig2_HTML
figtitle: Current understanding of epigenetics role in melanoma treatment and resistance
organisms:
- herbal medicine
- Lithospermum erythrorhizon
- Arnebia euchroma
- Onosma paniculata
- Mus musculus
- Rattus norvegicus
- Severe acute respiratory syndrome coronavirus 2
- Human papillomavirus type 16
- Homo sapiens
- Danio rerio
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Danio rerio
- Drosophila melanogaster
pmcid: PMC9555085
filename: 12935_2022_2738_Fig2_HTML.jpg
figlink: /pmc/articles/PMC9555085/figure/Fig2/
number: F2
caption: Histone lysine methyltransferases, namely KMT2D, EZH2, and SETDB1 can affect
  the advancement of melanoma cases. KMT2D can act as a regulator of IGFBP5 transcription
  to repress IGF1, thus inhibiting tumorigenesis. The SETDB1 can be triggered by Ret
  as a result of Src and PI3K pathway activation thenceforth, which affects AKT binding
  with SETDB1. This event leads to inhibiting pro-apoptotic genes such as Bim and
  Puma, and transcription blockade. EZH2 is involved in sundry signaling pathways
  such as Wnt/β-catenin, Ras, Notch, NF-KB, and β-adrenergic that deregulation of
  which can lead to tumorigenesis
papertitle: Current understanding of epigenetics role in melanoma treatment and resistance.
reftext: Mohsen Karami Fath, et al. Cancer Cell Int. 2022;22:313.
year: '2022'
doi: 10.1186/s12935-022-02738-0
journal_title: Cancer Cell International
journal_nlm_ta: Cancer Cell Int
publisher_name: BioMed Central
keywords: Melanoma | Epigenetics | Drug resistance | Immunotherapy
automl_pathway: 0.9652376
figid_alias: PMC9555085__F2
figtype: Figure
redirect_from: /figures/PMC9555085__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9555085__12935_2022_2738_Fig2_HTML.html
  '@type': Dataset
  description: Histone lysine methyltransferases, namely KMT2D, EZH2, and SETDB1 can
    affect the advancement of melanoma cases. KMT2D can act as a regulator of IGFBP5
    transcription to repress IGF1, thus inhibiting tumorigenesis. The SETDB1 can be
    triggered by Ret as a result of Src and PI3K pathway activation thenceforth, which
    affects AKT binding with SETDB1. This event leads to inhibiting pro-apoptotic
    genes such as Bim and Puma, and transcription blockade. EZH2 is involved in sundry
    signaling pathways such as Wnt/β-catenin, Ras, Notch, NF-KB, and β-adrenergic
    that deregulation of which can lead to tumorigenesis
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Igf1r
  - Igf1
  - Igfbp5
  - Akt1
  - Kmt2d
  - Cp
  - Setdb1
  - Gdnf
  - Ret
  - Src
  - Pik3r1
  - Gfra1
  - Ts2
  - Ts1
  - Ts3
  - Foxo1
  - Me3
  - Ctnnb1
  - Dact3
  - Ephb2
  - Mapk1
  - ras
  - Hras
  - Kras
  - Rem1
  - Dab2ip
  - Bcl2l11
  - Bbc3
  - Ezh2
  - Nfkb1
  - Adrb2
  - IGF1R
  - IGF1
  - IGFBP5
  - AKT1
  - AKT2
  - AKT3
  - KMT2D
  - CP
  - SETDB1
  - GDNF
  - RET
  - SRC
  - FGR
  - FYN
  - YES1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - GFRA1
  - FOXO1
  - ME3
  - PCDHGA5
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CTNNB1
  - DACT3
  - EPHB2
  - MAPK1
  - MAPK3
  - KRAS
  - HRAS
  - NRAS
  - DAB2IP
  - BCL2L11
  - BBC3
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - EZH2
  - NFKB1
  - ADRB2
  - Pik3cg
  - Wnt2
  - Ephb1
  - Notch1
  - igf1
  - igfbp5b
  - kmt2d
  - cp
  - setdb1a
  - gdnfa
  - ret
  - src
  - ccdc83
  - foxo1a
  - me3
  - ctnnb1
  - rab1ab
  - dab2ipb
  - bcl2l11
  - ezh2
  - Akt
  - egg
  - reticulated
  - reti
  - rets
  - Src42A
  - Csk
  - Src64B
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - foxo
  - Wnt5
  - Wnt4
  - wg
  - arm
  - Erk7
  - rl
  - Ras64B
  - Ras85D
  - .na.character
  - E(z)
  - Dif
  - dl
  - Rel
---
